Tikosyn
Product Images NDC 69189-5820

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tikosyn (NDC 69189-5820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avera Mckennan Hospital, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dofetilide 0.5 mg Capsule (6918958201)

This is a description of a medication containing lofetilide and tikosyn, manufactured by Pfizer. The lot number is N04369, and it is a 0.5mg capsule. The NDC is 6918958201, and it was received by Avera McKennan hospital in Sioux Falls, South Dakota on 03/28/2017. The hospital's lot number is APF16C28-U.*

FDA Label Image

Chemical Structure (Tikosyn 01)

FDA Label Image

Figure 1 (Tikosyn 02)

FDA Label Image

Figure 2 (Tikosyn 03)

FDA Label Image

Figure 3 (Tikosyn 04)

This appears to be a table displaying dosages and p-values for a certain drug (possibly named Dofetifde) in relation to a placebo. The dosages listed are 125 BID, 250 BID, and 500 BID. The p-values for each dosage are also shown for a "Log Rank Test" in relation to the placebo. It is unclear what the "T T T" and "o 3 3" represent. The table includes a time frame of "Time (Months)" but there is not enough information to determine what the time frame refers to.*

FDA Label Image

Figure 4 (Tikosyn 05)

This appears to be a table showing different doses of a medication called Dofetilide and their corresponding p-values when compared to a placebo using a Log Rank Test. The doses listed are 500mcg, 250mcg, and 125mcg to be taken twice a day (BID). The table also shows the p-values for each dose, with the 500mcg and 250mcg doses having p-values of 0.001 and the 125mcg dose having a p-value of 0.006. The data in the table may be related to a clinical trial or study measuring the effectiveness of Dofetilide over a period of time.*

FDA Label Image

Flow Chart (Tikosyn 06)

This is a medical text with instructions for the use of dofetilide, a medication used to treat heart arrhythmias. The text provides guidance on the administration of the drug, including dosing based on creatinine clearance, monitoring for changes in QT interval, and adjusting or discontinuing the drug as necessary. The use of dofetilide should be avoided in patients with low creatinine clearance and should be closely monitored for adverse effects on QT interval.*

FDA Label Image

Logo (Tikosyn 07)

This is a brief description of a product's distribution information. The product is distributed by Pfizer Labs, which is a division of Pfizer Inc. The location of Pfizer Inc is mentioned as NY, NY 10017.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.